Protara Therapeutics Q3 Results Due October 29; EPS Estimate $(0.37)
Protara Therapeutics is expected to report Q3'26 results on October 29. EPS is forecast at $(0.37); the release time is not specified.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.